EDMONTON, Alberta--(BUSINESS WIRE)--NanoSpeed Diagnostics, Inc. (“NanoSpeed”) is pleased to announce an expansion of their exclusive distribution agreement with global diagnostics and instrumentation ...

DiaSys Corp. DiaSys Corp. operates as a health card company engaged in the design, development, manufacture and distribution of workstation instruments, consumables, reagents and specialized test kits ...

Discover historical prices for DYXC stock on Yahoo Finance. View daily, weekly or monthly format back to when DiaSys Corporation stock was issued.

DiaSys Diagnostic Systems are an owner-managed medium-sized medical technology company with locations in Europe, Asia and Latin America. We develop and manufacture tests and systems for the diagnostic ...

The table below includes insider transactions amounts, trade dates and executives completing transactions. DIASYS CORP by DiaSys Corp. insider trades include the CEO, CFO, board of directors and is ...

DiaSys is an owner-managed medium-sized medical technology company and has a presence across Europe, Asia and Latin America. The deal signed on Monday will allow DiaSys to establish its presence in ...

DiaSys Corporation, a US-based healthcare products company, plans to further develop its three-year sales and service agreement with the Istanbul-based Ekin Medical, a Turkish diagnostics company.

New Delhi: Fair trade regulator CCI today approved acquisition of Piramal Enterprises' lab diagnostics and point-of-care business by DiaSys India. In 2014, Ajay Piramal-led Piramal Enterprises Ltd ...

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease, By Diagnostic Method, By Service Type, By End-use, By ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Visit a quote page and your recently viewed tickers will be displayed here.